Jounce Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Location
780 Memorial Drive, Cambridge, MA

There are no Buy or Sell transactions made by insiders since 11/21/2023

Jounce Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Concentra Biosciences, LLC 10%+ Owner $67.3M May 3, 2023
Third Rock Ventures II, L.P. 10%+ Owner $10.6M Sep 15, 2021
Third Rock Ventures III, L.P. 10%+ Owner $2.65M Nov 12, 2021
Hugh Cole Chief Operating Officer $204K Jan 9, 2023
Elizabeth Trehu Chief Medical Officer $191K Jan 9, 2023
Cary Pfeffer Director $93.4K Nov 12, 2021
Kevin Tang Director, 10%+ Owner $18.5K May 3, 2023
Richard /Ca/ Murray Director $2.00 May 3, 2023
Jigar Raythatha Director May 3, 2023
Barbara Gayle Duncan Director May 3, 2023
Kimberlee C. Drapkin President, CFO and Treasurer May 3, 2023
Perry A. Karsen Director May 3, 2023
Robert Iannone Director May 3, 2023
Robert Kamen Director May 3, 2023
Luis Diaz Director May 3, 2023
Luisa Salter-Cid Director May 3, 2023
John Duncan Higgons Director Jun 24, 2022

Recent Insider Transactions by Companies or Individuals for Jounce Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.